Commit To Buy Capricor Therapeutics At $3, Earn 69.5% Annualized Using Options
By Polaris Insights · Generated by the AI-powered Polaris Insight Engine · Published Oct 30, 2026, 9:18 AM PT · Updated Oct 30, 2026, 9:37 AM PT
Investors considering a purchase of Capricor Therapeutics Inc (Symbol: CAPR) shares, but cautious about paying the going market price of $6. 33/share, might benefit from considering selling puts among the alternative strategies at their disposal.